Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.56 |
| ▸ | CES2 | O00748 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3014435 | 0.93 | CES2 (0.58) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL16045044 | 0.93 | ALDH1A1 (0.56) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL28608548 | 0.91 | TSHR (0.60) | CES1CES2FAAHTSHRHCAR2 | |
| SCHEMBL8167954 | 0.91 | FAAH (0.61) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL9340088 | 0.91 | FAAH (0.61) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL2822696 | 0.91 | ALDH1A1 (0.54) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL3006961 | 0.91 | CES1 (0.56) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL8639413 | 0.89 | CES2 (0.58) | CES1CES2ALDH1A1FAAHTSHR | |
| SCHEMBL29747328 | 0.88 | AKR1B1 (0.50) | CES1CES2ALDH1A1FAAHATM | |
| SCHEMBL9002350 | 0.87 | FAAH (0.61) | CES1CES2FAAHTSHRNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9487602-B2 | Furan based resin, process for the preparation thereof, and use of the compound | DSM IP ASSETS B.V. (NL) | 2016-11-08 | — | — | US | claimed |
| US-20130109822-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2013-05-02 | — | — | US | claimed |
| US-20110306735-A1 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSM IP ASSETS B.V. (NL) | 2011-12-15 | — | — | US | claimed |
| US-20110021740-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2011-01-27 | — | — | US | claimed |
| EP-2222656-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP Assets B.V. (NL) | 2010-09-01 | — | — | EP | claimed |
| US-20090203851-A1 | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof | DSM IP ASSETS B.V. (NL) | 2009-08-13 | — | — | US | claimed |
| WO-2009077587-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2009-06-25 | — | — | WO | claimed |
| EP-2024317-A2 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSMIP Assets B.V. (NL) | 2009-02-18 | — | — | EP | claimed |
| WO-2007140941-A2 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSM IP ASSETS B.V. (NL) | 2007-12-13 | — | — | WO | claimed |
| US-9487602-B2 | Furan based resin, process for the preparation thereof, and use of the compound | DSM IP ASSETS B.V. (NL) | 2016-11-08 | — | — | US | disclosed |
| EP-1874407-B1 | SUBSTANCES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF GLYOXALASES AND THEIR USE AS ANTI-FUNGAL AGENTS | BIOMAC PRIVATINSTITUT FÜR MEDIZINISCHE UND ZAHNMEDIZINISCHE FORSCHUNG ENTWICKLUNG UND DIAGNOSTIK GMB (DE) | 2015-09-09 | — | — | EP | disclosed |
| EP-2226322-B1 | IMIDAZOLE CARBONYL COMPOUND | DAIICHI SANKYO CO LTD (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-8927588-B2 | Imidazole carbonyl compound | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-01-06 | — | — | US | disclosed |
| US-20140073622-A1 | IMIDAZOLE CARBONYL COMPOUND | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-03-13 | — | — | US | disclosed |
| WO-2003101973-A2 | NITROGEN-CONTAINING COMPOUND, THE PREPARATION THEREOF AND APPLICATION IN AMINO-ALDEHYDE RESINS | DSM IP ASSETS B.V. (NL) | 2003-12-11 | — | — | WO | disclosed |
| US-5981648-A | CURABLE LATEX COMPOSITION COMPRISING AN EMULSION IN AN AQUEOUS MEDIUM; DOES NOT LIBERATE FORMALDEHYDE ON CURING; COATINGS | AL CHEM & CY US ACQUICO, INC. | 1999-11-09 | — | — | US | disclosed |
| EP-0224736-B1 | Curable compositions | AMERICAN CYANAMID CO (US) | 1994-04-06 | — | — | EP | disclosed |
| US-4365086-A | CURING AGENTS FOR THERMOPLASTIC ELASTOMERS | PENNWALT CORPORATION (US) | 1982-12-21 | — | — | US | disclosed |
| US-4328360-A | VULCANIZING AGENT FOR THERMOPLASTIC RESINS | PENNWALT CORPORATION (US) | 1982-05-04 | — | — | US | disclosed |
| US-4052543-A | VULCANIZABLE AND VULCANIZED COMPOSITIONS CONTAINING POLYPEROXIDE | PENNWALT CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140073622-A1 | IMIDAZOLE CARBONYL COMPOUND | TOP1, TOP2B, TOP2A | CES1 692/4885CES2 2101/4885ALDH1A1 1220/4885 |
| US-20090203851-A1 | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof | HRH3, HRH1, C9 | CES1 2109/4885CES2 973/4885ALDH1A1 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.